Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios-Athanasios Dimopoulos

Showing results (231-240 of 283) with videos related to

Pageof 29
Sort By:
Current Issues in Molecular Biology|January 30, 2026
The Hippo Pathway in Metaplastic Breast Carcinoma: Prognostic Significance and Therapeutic ImplicationsEleni Papamattheou, Alkistis Papatheodoridi, Ioannis Katsaros, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 7, 2025
Evaluation of Clinical Characteristics and Prognostic Factors of Early Progressive Disease (EPD) in Newly Diagnosed Multiple Myeloma Patients: Real-World Data of the Greek Myeloma Study GroupEirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, et al.
European Journal of Haematology|July 12, 2024
An open-label, first-in-human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myelomaPrashant Kapoor, Nitya Nathwani, Tomas Jelinek, et al.
American Journal of Hematology|May 19, 2025
Cystatin C as Biomarker for the Evaluation of Renal Outcome in AL AmyloidosisFoteini Theodorakakou, Despina Fotiou, Filia Apostolakou, et al.
International Journal of Molecular Sciences|December 10, 2021
A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple MyelomaAristea-Maria Papanota, Paraskevi Karousi, Christos K Kontos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Primary treatment of Waldenström macroglobulinemia with dexamethasone, rituximab, and cyclophosphamideMeletios Athanasios Dimopoulos, Athanasios Anagnostopoulos, Marie-Christine Kyrtsonis, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 26, 2026
Proteostasis is disrupted in human endothelial cells by serum from ATTR patients and is rescued by tafamidis treatmentDespoina D Gianniou, Dimitrios Delialis, Georgios Georgiopoulos, et al.
The Science of the Total Environment|October 8, 2021
SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissionsAikaterini Galani, Reza Aalizadeh, Marios Kostakis, et al.
Basic Research in Cardiology|March 23, 2024
Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatinPanagiotis Efentakis, Angeliki Choustoulaki, Grzegorz Kwiatkowski, et al.
The Lancet. Haematology|July 27, 2024
Isatuximab plus carfilzomib-dexamethasone versus carfilzomib-dexamethasone in patients with relapsed multiple myeloma (IKEMA): overall survival analysis of a phase 3, randomised, controlled trialKwee Yong, Thomas Martin, Meletios-Athanasios Dimopoulos, et al.
Pageof 29

Showing results (231-240 of 283) with videos related to

Sort By:
Pageof 29
Current Issues in Molecular Biology|January 30, 2026
The Hippo Pathway in Metaplastic Breast Carcinoma: Prognostic Significance and Therapeutic ImplicationsEleni Papamattheou, Alkistis Papatheodoridi, Ioannis Katsaros, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 7, 2025
Evaluation of Clinical Characteristics and Prognostic Factors of Early Progressive Disease (EPD) in Newly Diagnosed Multiple Myeloma Patients: Real-World Data of the Greek Myeloma Study GroupEirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, et al.
European Journal of Haematology|July 12, 2024
An open-label, first-in-human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myelomaPrashant Kapoor, Nitya Nathwani, Tomas Jelinek, et al.
American Journal of Hematology|May 19, 2025
Cystatin C as Biomarker for the Evaluation of Renal Outcome in AL AmyloidosisFoteini Theodorakakou, Despina Fotiou, Filia Apostolakou, et al.
International Journal of Molecular Sciences|December 10, 2021
A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple MyelomaAristea-Maria Papanota, Paraskevi Karousi, Christos K Kontos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Primary treatment of Waldenström macroglobulinemia with dexamethasone, rituximab, and cyclophosphamideMeletios Athanasios Dimopoulos, Athanasios Anagnostopoulos, Marie-Christine Kyrtsonis, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 26, 2026
Proteostasis is disrupted in human endothelial cells by serum from ATTR patients and is rescued by tafamidis treatmentDespoina D Gianniou, Dimitrios Delialis, Georgios Georgiopoulos, et al.
The Science of the Total Environment|October 8, 2021
SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissionsAikaterini Galani, Reza Aalizadeh, Marios Kostakis, et al.
Basic Research in Cardiology|March 23, 2024
Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatinPanagiotis Efentakis, Angeliki Choustoulaki, Grzegorz Kwiatkowski, et al.
The Lancet. Haematology|July 27, 2024
Isatuximab plus carfilzomib-dexamethasone versus carfilzomib-dexamethasone in patients with relapsed multiple myeloma (IKEMA): overall survival analysis of a phase 3, randomised, controlled trialKwee Yong, Thomas Martin, Meletios-Athanasios Dimopoulos, et al.
Pageof 29